Cardioloxía
Servizo
Sergio
Manzano Fernández
Publicacións nas que colabora con Sergio Manzano Fernández (31)
2023
-
Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry
American Journal of Cardiovascular Drugs, Vol. 23, Núm. 1, pp. 77-87
2022
-
Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry
European Journal of Internal Medicine, Vol. 99, pp. 45-56
-
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry
BMC Medicine, Vol. 20, Núm. 1
-
Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry
Europace, Vol. 24, Núm. 5, pp. 721-728
-
Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registry
European Journal of Clinical Investigation, Vol. 52, Núm. 7
-
Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry
European Journal of Clinical Investigation, Vol. 52, Núm. 6
-
Ischemic-hemorrhagic balance in diabetic and non-diabetic patients after acute coronary syndrome
REC: CardioClinics, Vol. 57, Núm. 3, pp. 203-211
-
Safety and efficacy of different P2Y12 inhibitors in patients with acute coronary syndromes stratified by the PRAISE risk score: a multicentre study
European heart journal. Quality of care & clinical outcomes, Vol. 8, Núm. 8, pp. 881-891
2021
-
Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry
BMC Medicine, Vol. 19, Núm. 1
-
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets
The Lancet, Vol. 397, Núm. 10270, pp. 199-207
-
Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries
Cardiovascular Drugs and Therapy, Vol. 35, Núm. 6, pp. 1171-1182
-
Ticagrelor versus prasugrel in acute coronary syndrome: sex-specific analysis from the RENAMI Registry
Minerva cardiology and angiology, Vol. 69, Núm. 4, pp. 408-416
2020
-
Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registries
American Heart Journal, Vol. 220, pp. 108-115
-
Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor
International Journal of Cardiology, Vol. 301, pp. 200-206
-
Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries
American Journal of Cardiovascular Drugs, Vol. 20, Núm. 3, pp. 259-269
-
Incidence, prognosis and predictors of heart failure after acute myocardial infarction
REC: CardioClinics, Vol. 55, Núm. 1, pp. 8-14
-
Incidence, prognosis and predictors of heart failure after acute myocardial infarction
REC: CardioClinics, Vol. 55, Núm. 1, pp. 8-14
-
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry
European Journal of Preventive Cardiology, Vol. 27, Núm. 7, pp. 696-705
-
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects
European heart journal. Cardiovascular pharmacotherapy, Vol. 6, Núm. 1, pp. 31-42
2019
-
Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel
Revista Espanola de Cardiologia, Vol. 72, Núm. 4, pp. 298-304